1-3 of 3
Luis Chu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bendamustine, Bortezomib and Dexamethasone (BBD) As First-Line Treatment Of Patients (Pts) With Multiple Myeloma Who Are Not Candidates For High Dose Chemotherapy

Jesus Berdeja, MD, Michael Savona, MD, Luis Chu, MD, James Essell, MD, Patrick Murphy, MD, Todd Bauer, MD, Eric Raefsky, MD, Ralph V. Boccia, MD, Ian Flinn, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3193.
https://doi.org/10.1182/blood.V122.21.3193.3193
Published: 2013
Journal Articles

Bendamustine, Bortezomib and Dexamethasone (BBD) As First-Line Treatment of Patients with Multiple Myeloma Who Are Not Candidates for High Dose Chemotherapy: Toxicity Comparison of Two Dose Schedules

Jesus G. Berdeja, MD, Michael R. Savona, MD, FACP, James Essell, MD, Patrick Murphy, MD, Luis Chu, MD, Ralph V. Boccia, MD, Edward Arrowsmith, MD, MPH, Ian W. Flinn, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4047.
https://doi.org/10.1182/blood.V120.21.4047.4047
Published: 2012
Journal Articles

Thalidomide and rituximab in Waldenstrom macroglobulinemia

Clinical Trials & Observations
Steven P. Treon, Jacob D. Soumerai, Andrew R. Branagan, Zachary R. Hunter, Christopher J. Patterson, Leukothea Ioakimidis, Frederick M. Briccetti, Mark Pasmantier, Harvey Zimbler, Robert B. Cooper, Maria Moore, John Hill, II, Alan Rauch, Lawrence Garbo, Luis Chu, Cynthia Chua, Stephen H. Nantel, David R. Lovett, Hans Boedeker, Henry Sonneborn, John Howard, Paul Musto, Bryan T. Ciccarelli, Evdoxia Hatjiharissi, Kenneth C. Anderson
Journal: Blood
Blood (2008) 112 (12): 4452–4457.
https://doi.org/10.1182/blood-2008-04-150854
Published: 2008